Lockdowns delay new PolyNovo products says C.E.O.
SYDNEY: The development of new products in the pipeline for skin regeneration biotechnology ... read more
Blackmores boss now unsure on vaccine passports impact
MELBOURNE: Vitamins giant Blackmores is keen for COVID-19 vaccines to rollout and Australian ... read more
Altor Capital in 4 medtech plays for 2021
BRISBANE: Brisbane-based Altor Capital portfolio manager David McNamee specialises in investing in emerging ... read more
